{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T23:02:19Z","timestamp":1789081339964,"version":"build-2803163510"},"reference-count":58,"publisher":"Royal College of General Practitioners","issue":"679","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Gen Pract"],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>A growing demand for cancer genetic services has led to suggestions for the involvement of GPs. How, and in which conditions, they can be involved, and whether there are important barriers to implementation should be ascertained.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To review the tools available, clinician attitudes and experiences, and the effects on patients of genetic cancer risk assessment in general practice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design and setting<\/jats:title><jats:p>Systematic review of papers published worldwide between 1996 and 2017.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>The MEDLINE (via Ovid), EMBASE, Cochrane Library, CINAHL, and PsycINFO databases and grey literature were searched for entries dating from January 1996 to December 2017. Study quality was assessed with relevant Critical Appraisal Skills Programme tool checklists and a narrative synthesis of findings was conducted.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In total, 40 studies were included in the review. A variety of testing and screening tools were available for genetic cancer risk assessment in general practice, principally for breast, breast\u2013ovarian, and colorectal cancer risk. GPs often reported low knowledge and confidence to engage with genetic cancer risk assessment; however, despite time pressures and concerns about confidentiality and the impact of results on family members, some recognised the potential importance relating to such a development of the GP\u2019s role. Studies found few reported benefits for patients. Concerns about negative impacts on patient anxiety and cancer worries were largely not borne out.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>GPs may have a potential role in identifying patients at risk of hereditary cancer that can be facilitated by family-history tools. There is currently insufficient evidence to support the implementation of population-wide screening for genetic cancer risk, especially given the competing demands of general practice.<\/jats:p><\/jats:sec>","DOI":"10.3399\/bjgp18x700265","type":"journal-article","created":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T05:49:16Z","timestamp":1543902556000},"page":"e97-e105","source":"Crossref","is-referenced-by-count":25,"title":["Genetic cancer risk assessment in general practice: systematic review of tools available, clinician attitudes, and patient outcomes"],"prefix":"10.3399","volume":"69","author":[{"given":"Flore","family":"Laforest","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Kirkegaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baljinder","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1987","published-online":{"date-parts":[[2018,12,3]]},"reference":[{"key":"2020081209325864000_69.679.e97.1","unstructured":"World Health Organization (2018) Cancer. (WHO, Geneva) http:\/\/www.who.int\/cancer\/en\/ (accessed 22 Nov 2018)."},{"key":"2020081209325864000_69.679.e97.2","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/16.5.468"},{"key":"2020081209325864000_69.679.e97.3","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-016-3943-4"},{"issue":"10","key":"2020081209325864000_69.679.e97.4","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/GIM.0b013e318185212a","article-title":"Factors influencing the referrals in primary care of asymptomatic patients with a family history of cancer","volume":"10","author":"Al-Habsi","year":"2008","journal-title":"Genet Med"},{"key":"2020081209325864000_69.679.e97.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsb042979"},{"key":"2020081209325864000_69.679.e97.6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1497.2004.30401.x"},{"key":"2020081209325864000_69.679.e97.7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.322.7293.1027"},{"issue":"11","key":"2020081209325864000_69.679.e97.8","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/ejhg.2016.68","article-title":"Supporting genetics in primary care: investigating how theory can inform professional education","volume":"24","author":"Wilson","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"2020081209325864000_69.679.e97.9","first-page":"45","article-title":"Genetic susceptibility to cancer. Family physicians\u2019 experience","volume":"49","author":"Carroll","year":"2003","journal-title":"Can Fam Physician"},{"key":"2020081209325864000_69.679.e97.10","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/18.2.131"},{"key":"2020081209325864000_69.679.e97.11","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/16.4.426"},{"key":"2020081209325864000_69.679.e97.12","doi-asserted-by":"crossref","unstructured":"Mathers J Greenfield S Metcalfe A (2010) Family history in primary care: understanding GPs\u2019 resistance to clinical genetics \u2014 qualitative study. Br J Gen Pract, DOI: https:\/\/doi.org\/10.3399\/bjgp10X501868.","DOI":"10.3399\/bjgp10X501868"},{"issue":"4","key":"2020081209325864000_69.679.e97.13","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000362358","article-title":"Medical genetic counseling for breast cancer in primary care: a synthesis of major determinants of physicians\u2019 practices in primary care settings","volume":"17","author":"Jbilou","year":"2014","journal-title":"Public Health Genomics"},{"key":"2020081209325864000_69.679.e97.14","doi-asserted-by":"publisher","DOI":"10.1097\/GIM.0b013e31821afc8e"},{"issue":"2","key":"2020081209325864000_69.679.e97.15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s10549-016-3686-2","article-title":"A two-stage approach to genetic risk assessment in primary care","volume":"155","author":"Biswas","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"2020081209325864000_69.679.e97.16","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19970822)71:3<315::AID-AJMG12>3.0.CO;2-N"},{"key":"2020081209325864000_69.679.e97.17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.320.7231.354"},{"key":"2020081209325864000_69.679.e97.18","unstructured":"Critical Appraisal Skills Programme. CASP Tools & Checklists. http:\/\/www.casp-uk.net\/casp-tools-checklists (accessed 22 Nov 2018)."},{"issue":"1","key":"2020081209325864000_69.679.e97.19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0840-4704(10)60079-8","article-title":"How can we synthesize qualitative and quantitative evidence for healthcare policy-makers and managers?","volume":"19","author":"Pope","year":"2006","journal-title":"Healthc Manage Forum"},{"key":"2020081209325864000_69.679.e97.20","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/19.6.587"},{"key":"2020081209325864000_69.679.e97.21","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601348"},{"issue":"4","key":"2020081209325864000_69.679.e97.22","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3109\/13814780209160371","article-title":"Breast cancer genetics in primary care which GPs most accurately categorise patients at low risk?","volume":"8","author":"Hapgood","year":"2002","journal-title":"Eur J Gen Pract"},{"issue":"4","key":"2020081209325864000_69.679.e97.23","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1748-0361.2009.00246.x","article-title":"Cancer risk assessment by rural and Appalachian family medicine physicians","volume":"25","author":"Kelly","year":"2009","journal-title":"J Rural Health"},{"issue":"1","key":"2020081209325864000_69.679.e97.24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s12687-013-0173-x","article-title":"Cancer risk communication, predictive testing and management in France, Germany, the Netherlands and the UK: general practitioners\u2019 and breast surgeons\u2019 current practice and preferred practice responsibilities","volume":"5","author":"Nippert","year":"2014","journal-title":"J Community Genet"},{"key":"2020081209325864000_69.679.e97.25","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/18.5.491"},{"key":"2020081209325864000_69.679.e97.26","doi-asserted-by":"publisher","DOI":"10.1159\/000065170"},{"issue":"3","key":"2020081209325864000_69.679.e97.27","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/01.GIM.0000068986.03217.BB","article-title":"Predictive genetics in primary care: expectations for the motivational impact of genetic testing affects the importance family physicians place on screening for familial cancer risk","volume":"5","author":"Gramling","year":"2003","journal-title":"Genet Med"},{"key":"2020081209325864000_69.679.e97.28","doi-asserted-by":"publisher","DOI":"10.1370\/afm.60"},{"issue":"9","key":"2020081209325864000_69.679.e97.29","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/01.gim.0000187123.76699.e9","article-title":"Association between screening family medical history in general medical care and lower burden of cancer worry among women with a close family history of breast cancer","volume":"7","author":"Gramling","year":"2005","journal-title":"Genet Med"},{"issue":"10","key":"2020081209325864000_69.679.e97.30","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/01.gim.0000237769.59166.ad","article-title":"Self-rated breast cancer risk among women reporting a first-degree family history of breast cancer on office screening questionnaires in routine medical care: the role of physician-delivered risk feedback","volume":"8","author":"Gramling","year":"2006","journal-title":"Genet Med"},{"issue":"3","key":"2020081209325864000_69.679.e97.31","first-page":"176","article-title":"Should we test women for inherited susceptibility to breast cancer? What do NC primary care physicians think","volume":"58","author":"O\u2019Malley","year":"1997","journal-title":"N C Med J"},{"issue":"6","key":"2020081209325864000_69.679.e97.32","doi-asserted-by":"crossref","first-page":"e0178447","DOI":"10.1371\/journal.pone.0178447","article-title":"Validation of a scale for assessing attitudes towards outcomes of genetic cancer testing among primary care providers and breast specialists","volume":"12","author":"Bouhnik","year":"2017","journal-title":"PloS One"},{"issue":"3","key":"2020081209325864000_69.679.e97.33","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/imj.13357","article-title":"Breast and ovarian cancer referrals to the ACT Genetic Service: are we meeting guidelines?","volume":"47","author":"Aitken","year":"2017","journal-title":"Intern Med J"},{"key":"2020081209325864000_69.679.e97.34","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.319.7201.32"},{"issue":"1","key":"2020081209325864000_69.679.e97.35","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/gim.2013.75","article-title":"A cancer genetics toolkit improves access to genetic services through documentation and use of the family history by primary-care clinicians","volume":"16","author":"Scheuner","year":"2014","journal-title":"Genet Med"},{"issue":"2","key":"2020081209325864000_69.679.e97.36","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10689-013-9695-y","article-title":"Attitudes and knowledge of medical practitioners to hereditary cancer clinics and cancer genetic testing","volume":"13","author":"Teng","year":"2014","journal-title":"Fam Cancer"},{"issue":"10","key":"2020081209325864000_69.679.e97.37","first-page":"e626","article-title":"Primary care providers\u2019 experiences with and perceptions of personalized genomic medicine","volume":"62","author":"Carroll","year":"2016","journal-title":"Can Fam Physician"},{"key":"2020081209325864000_69.679.e97.38","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-9-283"},{"issue":"6","key":"2020081209325864000_69.679.e97.39","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s11606-013-2338-z","article-title":"Use of a web-based risk appraisal tool for assessing family history and lifestyle factors in primary care","volume":"28","author":"Baer","year":"2013","journal-title":"J Gen Intern Med"},{"key":"2020081209325864000_69.679.e97.40","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/16.1.71"},{"key":"2020081209325864000_69.679.e97.41","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7252.28"},{"issue":"1","key":"2020081209325864000_69.679.e97.42","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/ajmg.c.31388","article-title":"Implementing family health history risk stratification in primary care: impact of guideline criteria on populations and resource demand","volume":"166C","author":"Orlando","year":"2014","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"2020081209325864000_69.679.e97.43","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2010.000107"},{"key":"2020081209325864000_69.679.e97.44","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmi073"},{"key":"2020081209325864000_69.679.e97.45","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2296-14-111"},{"issue":"2","key":"2020081209325864000_69.679.e97.46","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10689-013-9693-0","article-title":"Evaluation after five years of the cancer genetic counselling programme of Valencian Community (Eastern Spain)","volume":"13","author":"Cuevas-Cuerda","year":"2014","journal-title":"Fam Cancer"},{"issue":"2","key":"2020081209325864000_69.679.e97.47","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1590\/1678-4685-gmb-2014-0362","article-title":"Self-reported cancer family history is a useful tool for identification of individuals at risk of hereditary cancer predisposition syndrome at primary care centers in middle-income settings: a longitudinal study.","volume":"39","author":"Fl\u00f3ria-Santos","year":"2016","journal-title":"Genet Mol Biol"},{"issue":"10","key":"2020081209325864000_69.679.e97.48","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/gim.2015.210","article-title":"Clinical utility of a web-enabled risk-assessment and clinical decision support program","volume":"18","author":"Orlando","year":"2016","journal-title":"Genet Med"},{"key":"2020081209325864000_69.679.e97.49","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.37.6.470"},{"key":"2020081209325864000_69.679.e97.50","doi-asserted-by":"crossref","unstructured":"Walter FM Prevost AT Birt L (2013) Development and evaluation of a brief self-completed family history screening tool for common chronic disease prevention in primary care. Br J Gen Pract, DOI: https:\/\/doi.org\/10.3399\/bjgp13X668186.","DOI":"10.3399\/bjgp13X668186"},{"key":"2020081209325864000_69.679.e97.51","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603897"},{"key":"2020081209325864000_69.679.e97.52","doi-asserted-by":"publisher","DOI":"10.1097\/GIM.0b013e3182241d88"},{"key":"2020081209325864000_69.679.e97.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2012.06.013"},{"issue":"7212","key":"2020081209325864000_69.679.e97.54","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/bmj.319.7212.757","article-title":"Evaluation of questionnaire on cancer family history in identifying patients at increased genetic risk in general practice","volume":"319","author":"Leggatt","year":"1999","journal-title":"BMJ"},{"key":"2020081209325864000_69.679.e97.55","doi-asserted-by":"publisher","DOI":"10.1136\/jms.6.4.205"},{"key":"2020081209325864000_69.679.e97.56","unstructured":"US Preventive Services Task Force (2013) Final recommendation statement: BRCA-related cancer \u2014 risk assessment, genetic counseling, and genetic testing. https:\/\/www.uspreventiveservicestaskforce.org\/Page\/Document\/RecommendationStatementFinal\/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing (accessed 22 Nov 2018)."},{"key":"2020081209325864000_69.679.e97.57","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/16.4.420"},{"issue":"4","key":"2020081209325864000_69.679.e97.58","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10689-008-9188-6","article-title":"Screen positive rates among six family history screening protocols for breast\/ovarian cancer in four cohorts of women","volume":"7","author":"McClain","year":"2008","journal-title":"Fam Cancer"}],"container-title":["British Journal of General Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3399\/bjgp18X700265","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T19:50:25Z","timestamp":1645818625000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjgp.org\/lookup\/doi\/10.3399\/bjgp18X700265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,3]]},"references-count":58,"journal-issue":{"issue":"679","published-online":{"date-parts":[[2019,1,31]]},"published-print":{"date-parts":[[2019,2]]}},"alternative-id":["10.3399\/bjgp18X700265"],"URL":"https:\/\/doi.org\/10.3399\/bjgp18x700265","relation":{},"ISSN":["0960-1643","1478-5242"],"issn-type":[{"value":"0960-1643","type":"print"},{"value":"1478-5242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,3]]}}}